跳至主要内容
临床试验/NCT01700478
NCT01700478已完成4 期

A Trial Comparing The Use Of Rectal Plus Perivascular Vasopressin With Perivascular Vasopressin Alone To Decrease Bleeding At The Time Of Myomectomy

University Hospital of the West Indies1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2005年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
45
试验地点
1
主要终点
Blood loss in millilitres

研究概览

简要总结

This study was done to determine if the use of a combination of preoperative rectal misoprostol 400µg used with intraoperative perivascular vasopressin is better than perivascular vasopressin used alone to decrease bleeding at myomectomy.

详细描述

A myomectomy is a fertility sparing procedure in which fibroids are removed from the uterus. This procedure can be associated with significant blood loss which can result in significant morbidity and mortality. The drug misoprostol which has been been use in the treatment of postpartum hemorrhage was given to subset of patients who were scheduled to undergo elective myomectomy at the University hospital of the West Indies and from the private practice of the participating doctors who were invited to participate in the study. Patients were randomized to receive or not to receive pre-operative rectal misoprostol 400µg, 60 minutes before surgery. Twenty five patients received misoprostol and twenty patients did not.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
25 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • patients with symptomatic fibroids who desire future fertility and or who wish to maintain their uterus.

排除标准

  • patients who have had previous myomectomy or previous pelvic surgery.
  • patients who are severely anemic or who have significant medical conditions such as cardiac or pulmonary disease.
  • patients who refuse to participate or give consent to the procedures. Patients with a known allergy to any of the study drugs.

研究组 & 干预措施

Misoprostol + vasopressin, Vasopressin

Experimental

Misoprostol 400ug given rectally one hour before surgery.

干预措施: Misoprostol + vasopressin (Drug)

Misoprostol + vasopressin, Vasopressin

Experimental

Misoprostol 400ug given rectally one hour before surgery.

干预措施: Vasopressin (Drug)

结局指标

主要结局

Blood loss in millilitres

时间窗: At the time of surgery

次要结局

  • A change in hemoglobin grams per decilitre(At baseline and 24hours after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Sharifa Frederick

Doctor

University Hospital of the West Indies

研究点 (1)

Loading locations...

相似试验